165 related articles for article (PubMed ID: 16785564)
1. Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1.
Behera AK; Hildebrand E; Uematsu S; Akira S; Coburn J; Hu LT
J Immunol; 2006 Jul; 177(1):657-64. PubMed ID: 16785564
[TBL] [Abstract][Full Text] [Related]
2. Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of pro-inflammatory mediators in primary human chondrocytes.
Behera AK; Durand E; Cugini C; Antonara S; Bourassa L; Hildebrand E; Hu LT; Coburn J
Cell Microbiol; 2008 Feb; 10(2):320-31. PubMed ID: 17822440
[TBL] [Abstract][Full Text] [Related]
3. MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi.
Behera AK; Hildebrand E; Bronson RT; Perides G; Uematsu S; Akira S; Hu LT
Infect Immun; 2006 Mar; 74(3):1462-70. PubMed ID: 16495516
[TBL] [Abstract][Full Text] [Related]
4. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice.
Liu N; Montgomery RR; Barthold SW; Bockenstedt LK
Infect Immun; 2004 Jun; 72(6):3195-203. PubMed ID: 15155621
[TBL] [Abstract][Full Text] [Related]
5. Live Borrelia burgdorferi spirochetes elicit inflammatory mediators from human monocytes via the Toll-like receptor signaling pathway.
Dennis VA; Dixit S; O'Brien SM; Alvarez X; Pahar B; Philipp MT
Infect Immun; 2009 Mar; 77(3):1238-45. PubMed ID: 19139200
[TBL] [Abstract][Full Text] [Related]
6. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease.
Bolz DD; Sundsbak RS; Ma Y; Akira S; Kirschning CJ; Zachary JF; Weis JH; Weis JJ
J Immunol; 2004 Aug; 173(3):2003-10. PubMed ID: 15265935
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi.
Wooten RM; Ma Y; Yoder RA; Brown JP; Weis JH; Zachary JF; Kirschning CJ; Weis JJ
J Immunol; 2002 Jan; 168(1):348-55. PubMed ID: 11751980
[TBL] [Abstract][Full Text] [Related]
8. Adaptor Protein-3-Mediated Trafficking of TLR2 Ligands Controls Specificity of Inflammatory Responses but Not Adaptor Complex Assembly.
Petnicki-Ocwieja T; Kern A; Killpack TL; Bunnell SC; Hu LT
J Immunol; 2015 Nov; 195(9):4331-40. PubMed ID: 26423153
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88.
Joosten LA; Koenders MI; Smeets RL; Heuvelmans-Jacobs M; Helsen MM; Takeda K; Akira S; Lubberts E; van de Loo FA; van den Berg WB
J Immunol; 2003 Dec; 171(11):6145-53. PubMed ID: 14634130
[TBL] [Abstract][Full Text] [Related]
10. Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways.
Behera AK; Thorpe CM; Kidder JM; Smith W; Hildebrand E; Hu LT
Infect Immun; 2004 May; 72(5):2864-71. PubMed ID: 15102798
[TBL] [Abstract][Full Text] [Related]
11. Phagocytic Receptors Activate Syk and Src Signaling during Borrelia burgdorferi Phagocytosis.
Killpack TL; Ballesteros M; Bunnell SC; Bedugnis A; Kobzik L; Hu LT; Petnicki-Ocwieja T
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28717031
[TBL] [Abstract][Full Text] [Related]
12. MyD88 deficiency enhances acquisition and transmission of Borrelia burgdorferi by Ixodes scapularis ticks.
Bockenstedt LK; Liu N; Schwartz I; Fish D
Infect Immun; 2006 Apr; 74(4):2154-60. PubMed ID: 16552045
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.
Zhai Y; Shen XD; O'Connell R; Gao F; Lassman C; Busuttil RW; Cheng G; Kupiec-Weglinski JW
J Immunol; 2004 Dec; 173(12):7115-9. PubMed ID: 15585830
[TBL] [Abstract][Full Text] [Related]
14. Dual role for Fcγ receptors in host defense and disease in Borrelia burgdorferi-infected mice.
Belperron AA; Liu N; Booth CJ; Bockenstedt LK
Front Cell Infect Microbiol; 2014; 4():75. PubMed ID: 24967215
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction.
Shin OS; Isberg RR; Akira S; Uematsu S; Behera AK; Hu LT
Infect Immun; 2008 Jun; 76(6):2341-51. PubMed ID: 18378636
[TBL] [Abstract][Full Text] [Related]
16. Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice.
Liu-Bryan R; Terkeltaub R
Arthritis Rheum; 2010 Jul; 62(7):2004-12. PubMed ID: 20506365
[TBL] [Abstract][Full Text] [Related]
17. Invasion of eukaryotic cells by Borrelia burgdorferi requires β(1) integrins and Src kinase activity.
Wu J; Weening EH; Faske JB; Höök M; Skare JT
Infect Immun; 2011 Mar; 79(3):1338-48. PubMed ID: 21173306
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory mediator release from primary rhesus microglia in response to Borrelia burgdorferi results from the activation of several receptors and pathways.
Parthasarathy G; Philipp MT
J Neuroinflammation; 2015 Mar; 12():60. PubMed ID: 25889406
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease.
Schröder NW; Diterich I; Zinke A; Eckert J; Draing C; von Baehr V; Hassler D; Priem S; Hahn K; Michelsen KS; Hartung T; Burmester GR; Göbel UB; Hermann C; Schumann RR
J Immunol; 2005 Aug; 175(4):2534-40. PubMed ID: 16081826
[TBL] [Abstract][Full Text] [Related]
20. Signaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme disease.
Benhnia MR; Wroblewski D; Akhtar MN; Patel RA; Lavezzi W; Gangloff SC; Goyert SM; Caimano MJ; Radolf JD; Sellati TJ
J Immunol; 2005 Feb; 174(3):1539-48. PubMed ID: 15661914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
